National Bank of Canada’s Pulse Biosciences PLSE Stock Holding History

National Bank of Canada’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.6K	Sell	493 -7	-1%	-$129	﹤0.01%	2316
2025 Q4	$6.87K	Hold	500	–	–	﹤0.01%	2383
2025 Q3	$8.82K	Sell	500 -822	-62%	-$13K	﹤0.01%	2351
2025 Q2	$19.9K	Sell	1,322 -90	-6%	-$1.49K	﹤0.01%	2178
2025 Q1	$22.6K	Sell	1,412 -65	-4%	-$1.21K	﹤0.01%	2058
2024 Q4	$25.7K	Sell	1,477 -24	-2%	-$423	﹤0.01%	2118
2024 Q3	$26.3K	Sell	1,501 -499	-25%	-$8.51K	﹤0.01%	1877
2024 Q2	$21.5K	Hold	2,000	–	–	﹤0.01%	1953
2024 Q1	$14.9K	Hold	2,000	–	–	﹤0.01%	2093
2023 Q4	$22K	Hold	2,000	–	–	﹤0.01%	1999
2023 Q3	$8.02K	Sell	2,000 -1,000	-33%	-$6.21K	﹤0.01%	2247
2023 Q2	$21K	Buy	3,000 +1,000	+50%	+$6.39K	﹤0.01%	2001
2023 Q1	$6.71K	Hold	2,000	–	–	﹤0.01%	2234
2022 Q4	$5.44K	Buy	+2,000	New	+$4.49K	﹤0.01%	2313

Other funds holding PLSE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

National Bank of Canada's PLSE Position: Q1 2026 in Review

National Bank of Canada reduced its Pulse Biosciences (PLSE) stake by 1.4% in Q1 2026, selling an estimated $129 and leaving 493 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2316.

National Bank of Canada first reported a position in PLSE in Q4 2022 and has held it in 14 quarters since. The position peaked at $26.3K in Q3 2024. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

National Bank of Canada held 493 shares of Pulse Biosciences worth $10.6K as of Q1 2026.
National Bank of Canada sold 7 Pulse Biosciences shares in Q1 2026, an estimated $129.
Pulse Biosciences made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2316 holding.
National Bank of Canada first reported a position in Pulse Biosciences in Q4 2022 and has held it in 14 quarters since.
National Bank of Canada's Pulse Biosciences position peaked at $26.3K in Q3 2024.
96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.